Stress Inoculation Training (SIT): An Evidence-Based, Military Aligned Psychological Performance and Health Sustainment Prototype

The University of Texas System (UT)

Status

Begins enrollment this month

Conditions

Stress, Psychological

Treatments

Behavioral: SIT

Behavioral: DCA-FF

Study type

Interventional

Funder types

Other

Identifiers

NCT06656780

HSC-MS-24-0756

Details and patient eligibility

About

The purpose of this study is to demonstrate the feasibility of augmenting existing/traditional Navy military training with the manualized SIT Core Protocol (CP) utilizing the established augmentation procedure set as measured by feasibility, utility, and satisfaction metrics (CSQ-8) and to examine the relative effectiveness of the SIT-CP by comparison to standard military training in a controlled trial examining outcomes of stress tolerance, psychological health, resilience and occupational performance in Sailors undergoing DCA Firefighting Training (pre- to post-training), while collecting implementation data.

Enrollment

120 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

US Navy service members on Active Duty or Reserve status
be fluent in English.
be capable of giving signed informed consent which includes compliance with the requirements and restrictions listed in the informed consent form and in this protocol.
have access to a SmartPhone, computer, or tablet to utilize and access the virtual classroom.
agree to undergo psychometric and operational performance testing and participate in ongoing assessments throughout the study duration.
be willing to comply with all study procedures, able to complete all assessments independently, and available for the duration of the study (with reasonable accommodations for military operational demands as they arise).

Exclusion criteria

Active suicidal ideation as assessed by the Investigator at screening or as identified during the study.
Clinically significant history of psychotic disorder, bipolar spectrum disorder, or neurodegenerative disease/dementia as assessed by the Investigator.
Active severe substance abuse as assessed by the investigator in accordance with The Diagnostic and Statistical Manual of Mental Illnesses (DSM-5) Substance Abuse Disorder criteria, or presence of illicit substance abuse.
They are currently undergoing another form of treatment other than supportive therapy (>2 times per month).
Any other condition/situation that the Investigator believes may interfere with participant safety, study conduct, or interpretation of study data.